21 Results for "

Benzamide derivatives

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "Benzamide derivatives" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B0068
CAS No.: 123040-16-4
Synonyms: Y-25130 hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
Cat. No.: HY-Q49697
CAS No.: 708995-11-3
Target:  

Sirtuin

Sirtuin modulator 3 (compound 129) is a N-phenyl benzamide derivative, acts as a sirtuin modulator .
loading...
    loading...
Cat. No.: HY-169823
CAS No.: 218936-13-1
Research Areas:  

Infection

BAS-118 is a benzamide derivative with antibacterial activity. The MIC50, MIC90 and MIC ranges of BAS-118 for 100 randomly selected isolates of Helicobacter pylori are ≤0.003, 0.013 and ≤0.003-0.025 mg/L, respectively. BAS-118 is promising for research of anti-H. pylori agent .
loading...
    loading...
Cat. No.: HY-149800
CAS No.: 2976342-33-1
Purity:  99.30%
Target:  

PARP Apoptosis Caspase

Research Areas:  

Cancer

PARP-1-IN-3, a benzamide derivative, is a potent PARP-1 inhibitor with IC50 values of 0.25 nM and 2.34 nM for PARP-1 and PARP-2, respectively. PARP-1-IN-3 induces apoptosis and arrest cell cycle at G2/M phase. PARP-1-IN-3 can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-U00415
CAS No.: 108226-05-7
Target:  

Dopamine Receptor mAChR

Research Areas:  

Neurological Disease

Benzamide Derivative 1 is a benzamide derivative from patent EP0213775A1, compound 18. Benzamide Derivative 1 may be useful in treatment of gastrointestinal disorders.
loading...
    loading...
Cat. No.: HY-U00020
CAS No.: 287399-47-7
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease

AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
loading...
    loading...
Cat. No.: HY-100963
CAS No.: 112465-94-8
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

U-54494A is a benzamide derivative related to κ-opioid receptor agonists, U-54494A has an anticonvulsant activity .
loading...
    loading...
Cat. No.: HY-W128037
CAS No.: 4299-03-0
Research Areas:  

Others

(S)-N-(1-Amino-5-guanidino-1-oxopentan-2-yl)benzamide hydrochloride is an arginine derivative .
loading...
    loading...
Cat. No.: HY-B0732S
CAS No.: 1346601-02-2
Synonyms: HSR803-d6 hydrochloride
Itopride-d6 (hydrochloride) is deuterium labeled Itopride (hydrochloride). Itopride hydrochloride (HSR803), a gastroprokinetic Benzamide (HY-Z0283) derivative, is an inhibitor of acetylcholinesterase (AChE) and dopamine D2 receptor .
loading...
    loading...
Cat. No.: HY-163847
Target:  

MMP Cathepsin

Research Areas:  

Inflammation/Immunology

Anti-osteoporosis agent-9 (compound 5b) is a N-cyclopropyl-4-((4-((4-(trifluoromethyl)phenyl)sulfonyl)piperazin-1-yl)methyl)benzamide derivative that shows anti-osteoclast activity .
loading...
    loading...
Cat. No.: HY-B0068R
CAS No.: 123040-16-4
Research Areas:  

Neurological Disease

Azasetron (hydrochloride) (Standard) is the analytical standard of Azasetron (hydrochloride). This product is intended for research and analytical applications. Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV) .
loading...
    loading...
Cat. No.: HY-155355
Target:  

iGluR

Research Areas:  

Neurological Disease

LY836 is an orally active neuroprotective agent. LY836 significantly blocks PSD95-nNOS association in cortical neurons. LY836 can be used in study ischemic stroke .
loading...
    loading...
Cat. No.: HY-146123
CAS No.: 2691937-03-6
Research Areas:  

Cancer

ATX inhibitor 20 (compound 24) is a potent ATX (autotaxin) inhibitor, with an IC50 of 2.3 nM .
loading...
    loading...
Cat. No.: HY-167866
CAS No.: 125279-79-0
Ersentilide, a benzamide derivative, is a is a β1-adrenoceptor antagonist and Ikr blocker. Ersentilide is effective in several intact animal models of arrhythmia .
loading...
    loading...
Cat. No.: HY-183490
CAS No.: 1263402-76-1
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

Glucokinase activator 11 is a substituted benzamide derivative and glucokinase activator. Glucokinase activator 11 can be used for the research of type ii diabetes .
loading...
    loading...
Cat. No.: HY-153500
CAS No.: 1616368-12-7
Target:  

Hedgehog

Research Areas:  

Others

Hedgehog IN-4 is a benzamide derivative and also an inhibitor of the Hedgehog signaling pathway, with an IC50 of 0.050 nM .
loading...
    loading...
Cat. No.: HY-184901
CAS No.: 2789716-24-9
Target:  

GlyT

Research Areas:  

Neurological Disease

GLyT2-IN-3 is a potent GlyT2 inhibitor with a KD of 23.7 nM. GLyT2-IN-3 inhibits GlyT2-mediated glycine uptake with an IC50 of 19.4 nM. GLyT2-IN-3 shows broad-spectrum antinociceptive effects in three pain models, does not induce sedative effects or motor coordination impairment in mice, and exhibits favorable pharmacokinetic properties in rats with an oral bioavailability of 88.57%, GLyT2-IN-3 can be used for the study of neuropathic pain .
loading...
    loading...
Cat. No.: HY-123332
CAS No.: 73328-60-6
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

YM-08050 is a new anti-psychotic and Benzamide (HY-Z0283) derivative. YM-08050 inhibits stereotyped behaviors, conditioned avoidance responses, or spontaneous movements induced by Apomorphine (HY-12723) or Methamphetamine .
loading...
    loading...
Cat. No.: HY-186238
CAS No.: 1440797-80-7
Target:  

GlyT 5-HT Receptor

Research Areas:  

Neurological Disease

VVZ-068 is a benzamide derivative and also a GlyT2/5HT2A antagonist. VVZ-068 alleviates neuropathic mechanical hyperalgesia in a rat model of mechanical allodynia. VVZ-068 is applicable for pain-related research .
loading...
    loading...
Cat. No.: HY-180281
CAS No.: 3099026-16-8
Research Areas:  

Cancer

PLAGL2-IN-1 is a inhibitor of pleiomorphic adenoma-like protein 2 (PLAGL2) with a Kd of 2.23 µM. PLAGL2-IN-1 suppresses PLAGL2 transcriptional activity, induces G0/G1 cell cycle arrest, and apoptosis, thereby inhibiting hepatocellular carcinoma (HCC) cell proliferation. PLAGL2-IN-1 disrupts extracellular matrix organization and suppresses the PI3K-AKT pathway by reducing AKT phosphorylation. PLAGL2-IN-1 inhibits tumor growth in an HCCLM3 xenograft mouse model. PLAGL2-IN-1 can be used for the research of HCC .
loading...
    loading...